Use of bv8 antagonists for preparation of medicaments for use in neoplastic and non-neoplastic therapy

摘要

The present invention relates generally to the inhibition of inflammatory cell-mediated angiogenesis. In particular, the invention concerns the prevention or treatment of tumor angiogenesis, and the inhibition of tumor development, using Bv8 antagonists, such as anti-Bv8 antibodies.